In The Spotlight
DDNews Cancer Research Exclusive
Recent work with nanoparticles offers a new approach to photo-thermal cancer therapies
(Photo credit: University of Toronto)
The PEARLs (Photothermal Enhancing Auto-Regulated Liposomes) were developed by Dr. Gang Zheng of the Princess Margaret Cancer Centre and University of Toronto and colleagues, who say they overcome traditional roadblocks to penetrate deeper into tumors.
Breast cancer screening found effective in men at high risk for the disease
The Genomics of Drug Sensitivity in Cancer project recently released data from four years of work
Repositive makes cancer models publicly browsable
HERA-GITRL shows potent, specific targeting in cancer animal models
Chimerix secures license to AML candidate with unique mechanism of action
Ziopharm’s Controlled interleukin 12 seems to improve T cell recruitment with less toxicity than past IL-12 therapies
Mayo and TGen join hands with Cambridge on test to improve, personalize breast cancer treatment
Agendia announces publication of study validating use of MammaPrint and BluePrint
Glioblastoma remains a difficult cancer to treat, but the brain malignancy is seeing increasing attention in R&D
by Martin Lachs/Brandon Fletcher
As excitement and investment related to adoptive cell transfer products increases, there are concerns and issues that need to be addressed in terms of long-term follow-up trials

by Sue Cramp, Charles River
In pursuit of new options for treating childhood cancers, a new approach to drug discovery and development may be an answer

by Andrea Toell of Lonza
Andrea Toell of Lonza shares how CAR T cells are transforming immuno-oncology

Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.